The memory disorders drug pipeline is growing due to rising dementia and Alzheimer’s cases, with focus on disease-modifying therapies, neuroprotective agents, and innovative biomarker research. https://mushlovesocial.com/blogs/54137/Memory-Disorders-Drug-Pipeline-Analysis-Market-Growth-and-Future-Outlook